A C Altamura - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A C Altamura

Showing results (71-80 of 113) with videos related to

Pageof 12

Sort By:

L'Encephale|January 1, 1986

Combination therapy with haloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic studyA C Altamura, M Buccio, G Colombo, et al.

Minerva Psichiatrica|June 1, 1994

[Multinational validation of the Composite International Diagnostic Interview (CIDI)]G Tacchini, M T Coppola, A Musazzi, et al.

Journal of Affective Disorders|April 8, 2018

Gray matter differences between affective and non-affective first episode psychosis: A review of Magnetic Resonance Imaging studies: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disordersA Calvo, G Delvecchio, A C Altamura, et al.

Journal of Affective Disorders|February 5, 2017

The putative role of neuronal network synchronization as a potential biomarker for bipolar disorder: A review of EEG studiesE Maggioni, A M Bianchi, A C Altamura, et al.

Pharmacopsychiatry|November 1, 1989

Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrineA C Altamura, M C Mauri, F De Novellis, et al.

L'Encephale|January 1, 1981

Therapeutic plasma levels of some anticonvulsants in focal epilepsy in relation to computerized axial tomographyC L Cazzullo, A C Altamura, C M Cornaggia, et al.

Expert Opinion on Drug Safety|February 1, 2017

Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluationM C Mauri, A Reggiori, S Paletta, et al.

CNS Spectrums|May 23, 2008

Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorderA C Altamura, Bernardo Dell'osso, Nazario D'Urso, et al.

Psychopharmacology Series|January 1, 1989

Hydroxyhaloperidol and clinical outcome in schizophreniaA C Altamura, M Mauri, R Cavallaro, et al.

European Archives of Psychiatry and Clinical Neuroscience|February 3, 1999

Prevalence of somatoform disorders in a psychiatric population: an Italian nationwide survey. Italian Collaborative Group on Somatoform DisordersA C Altamura, M G Carta, G Tacchini, et al.

Pageof 12

Search research articles

Showing results (71-80 of 113) with videos related to

Sort By:

Pageof 12

L'Encephale|January 1, 1986

Combination therapy with haloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic studyA C Altamura, M Buccio, G Colombo, et al.

Minerva Psichiatrica|June 1, 1994

[Multinational validation of the Composite International Diagnostic Interview (CIDI)]G Tacchini, M T Coppola, A Musazzi, et al.

Journal of Affective Disorders|April 8, 2018

Journal of Affective Disorders|February 5, 2017

The putative role of neuronal network synchronization as a potential biomarker for bipolar disorder: A review of EEG studiesE Maggioni, A M Bianchi, A C Altamura, et al.

Pharmacopsychiatry|November 1, 1989

Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrineA C Altamura, M C Mauri, F De Novellis, et al.

L'Encephale|January 1, 1981

Therapeutic plasma levels of some anticonvulsants in focal epilepsy in relation to computerized axial tomographyC L Cazzullo, A C Altamura, C M Cornaggia, et al.

Expert Opinion on Drug Safety|February 1, 2017

Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluationM C Mauri, A Reggiori, S Paletta, et al.

CNS Spectrums|May 23, 2008

Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorderA C Altamura, Bernardo Dell'osso, Nazario D'Urso, et al.

Psychopharmacology Series|January 1, 1989

Hydroxyhaloperidol and clinical outcome in schizophreniaA C Altamura, M Mauri, R Cavallaro, et al.

European Archives of Psychiatry and Clinical Neuroscience|February 3, 1999

Prevalence of somatoform disorders in a psychiatric population: an Italian nationwide survey. Italian Collaborative Group on Somatoform DisordersA C Altamura, M G Carta, G Tacchini, et al.

Pageof 12